Deborah J. Neff - Jun 5, 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Stock symbol
CTKB
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 06:59 PM
Previous filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Award $0 +15.7K $0.00 15.7K Jun 5, 2024 Common Stock 15.7K Direct F1, F2
transaction CTKB Stock Option (right to buy) Award $0 +23.1K $0.00 23.1K Jun 5, 2024 Common Stock 23.1K $5.73 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 100% of the shares subject to the RSU Award shall vest on June 5, 2025.